Brown Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,580,875
Closed -$16.8M 134
2024
Q2
$16.8M Sell
2,580,875
-119,830
-4% -$781K 0.34% 45
2024
Q1
$23.5M Sell
2,700,705
-1,008,726
-27% -$8.79M 0.42% 43
2023
Q4
$42.4M Sell
3,709,431
-10,365
-0.3% -$119K 0.64% 35
2023
Q3
$35.8M Sell
3,719,796
-31,802
-0.8% -$306K 0.55% 36
2023
Q2
$39.9M Sell
3,751,598
-182,335
-5% -$1.94M 0.57% 35
2023
Q1
$41.4M Sell
3,933,933
-63,112
-2% -$664K 0.62% 36
2022
Q4
$49.5M Sell
3,997,045
-4,640,073
-54% -$57.5M 0.82% 34
2022
Q3
$89.5M Sell
8,637,118
-3,004,817
-26% -$31.1M 1.25% 28
2022
Q2
$134M Sell
11,641,935
-2,587,064
-18% -$29.8M 1.8% 24
2022
Q1
$179M Sell
14,228,999
-2,028,900
-12% -$25.5M 1.78% 23
2021
Q4
$190M Sell
16,257,899
-746,496
-4% -$8.7M 1.57% 22
2021
Q3
$222M Sell
17,004,395
-1,480,364
-8% -$19.3M 1.82% 20
2021
Q2
$238M Sell
18,484,759
-1,685,367
-8% -$21.7M 1.8% 24
2021
Q1
$226M Buy
20,170,126
+19,663
+0.1% +$220K 1.68% 25
2020
Q4
$230M Buy
20,150,463
+47,171
+0.2% +$537K 1.59% 24
2020
Q3
$181M Buy
20,103,292
+1,305,231
+7% +$11.7M 1.5% 24
2020
Q2
$194M Buy
18,798,061
+837,212
+5% +$8.64M 1.67% 23
2020
Q1
$181M Buy
17,960,849
+59,796
+0.3% +$603K 2.1% 24
2019
Q4
$238M Sell
17,901,053
-29,728
-0.2% -$396K 2.28% 23
2019
Q3
$154M Buy
17,930,781
+5,600,891
+45% +$48.1M 1.49% 26
2019
Q2
$135M Sell
12,329,890
-116
-0% -$1.27K 1.28% 29
2019
Q1
$140M Buy
12,330,006
+235,585
+2% +$2.67M 1.41% 29
2018
Q4
$105M Buy
12,094,421
+4,393,705
+57% +$38.1M 1.26% 29
2018
Q3
$119M Buy
7,700,716
+172,002
+2% +$2.66M 1.08% 27
2018
Q2
$121M Buy
7,528,714
+48,513
+0.6% +$777K 1.24% 25
2018
Q1
$96.7M Buy
7,480,201
+1,194
+0% +$15.4K 1.1% 26
2017
Q4
$93.9M Buy
7,479,007
+55,222
+0.7% +$693K 1.14% 27
2017
Q3
$98.1M Buy
7,423,785
+1,793
+0% +$23.7K 1.19% 27
2017
Q2
$117M Buy
7,421,992
+1,343,250
+22% +$21.2M 1.44% 26
2017
Q1
$86.9M Buy
+6,078,742
New +$86.9M 1.16% 28